TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Cann Group ( (AU:CAN) ) is now available.
Cann Group Limited has announced a significant restructuring of its debt and a capital raise, which includes a major debt forgiveness agreement with National Australia Bank, reducing its outstanding loan balance by 81%. The company has also secured a new loan from an existing lender and commitments for a $9 million capital raise through institutional placement and a share purchase plan. This financial restructuring is expected to improve Cann Group’s financial stability and market position, with projected revenue growth and a reduction in EBITDA losses by FY26.
More about Cann Group
Cann Group Limited is an Australian company operating in the medicinal cannabis industry. The company focuses on the cultivation and production of cannabis products for medical purposes, aiming to serve both domestic and international markets.
YTD Price Performance: -64.10%
Average Trading Volume: 2,441,445
Technical Sentiment Signal: Sell
Current Market Cap: A$9.85M
Find detailed analytics on CAN stock on TipRanks’ Stock Analysis page.